Who We Are

The Extracorporeal Life Support Organization (ELSO) is the premier global organization providing education, training, research, and data management for the advancement of extracorporeal life support. ELSO maintains a comprehensive ECMO patient registry since 1989, comprised of over 160,000 ECMO cases.


Notice:

ELSO 32nd Annual Meeting

Please plan on attending ELSO's 32nd annual meeting September 30th to October 1st. Registration is now open! Abstract submission open - deadline is July 15th. Details on the meeting page.
Meeting Page

ELSO 2022 Research Grant Application

The ELSO Research Grant Application process is now open. Deadline to submit is September 30, 2021. Please use the link below for more detailed information. You must log in prior to applying.
ELSO Research Grant Application

ELSO Mailing Address

Please update your records with ELSO's updated mailing address:

ELSO Office
3001 Miller Rd
Ann Arbor, MI, 48103 USA

Guidelines for ECMO in COVID-19 patients

ELSO has prepared an in-depth set of guidelines for ECMO in COVID-19 patients. These have been collaboratively developed by a global team of ECMO experts. The guidelines include: patient selection criteria, cannulation and decannulation strategies, transport on ECMO, PPE and staff protection strategies with ECMO, to ethical dilemmas and quality. ELSO wants to recognize the leadership of Kiran Shekar in chairing the development of these guidelines during a critical time.
Guidelines for ECMO in COVID-19 patients Link

ECMO Capacity Map

ELSO has developed a map that quickly shows ECMO capacity (map: https://www.elso.org/Membership/CenterMap.aspx). Center administrators can update the capacity here: http://www.elso.org/UpdateECMOCapacity) or from the Manage - Manage Center Details section.


COVID-19 Cases on ECMO in the ELSO Registry
Total COVID-19 Cases COVID-19
Suspected or Confirmed
8160
COVID-19
Confirmed Cases
8131
Total counts of COVID-19 confirmed patients and count of COVID-19 suspected but not confirmed by testing.
Patients who initiated ECMO at
least 90 days ago
COVID-19
Confirmed
6868
COVID-19
In-hospital Mortality
48%
COVID-19 ECMO counts by ELSO Chapter
North America 5128
Europe 1832
Asia Pacific 114
Latin America 567
SWAAC 519

FULL COVID-19 REGISTRY DASHBOARD

Disclaimer

Individual Membership

As a member, you can contribute to and use registry data, benchmark patient outcomes, request data for research, and gain education and training. We offer three membership levels: center, corporate and individual. Learn more about the benefits and apply online.

Individual Membership

Our discussion board, presentations, job listings, newsletters, guidelines, articles and other useful information help ELSO centers perform at the top of their game. We also help patients, their families and caregivers understand ECMO.

Individual Membership

Join the discussion and foster communication and collaboration among professionals who apply advanced technologies in treating refractory organ failure.

Meetings

32nd Annual ELSO Conference 09/30/2021 - 10/01/2021
Location: Virtual
ELSOConference@elso.org
Posted Date: 05/26/2020
website »

APELSO 2021 Meeting 10/28/2021 - 10/31/2021
Location: Taipei, Taiwan
Ms. Molly Hsiao +886-2-2798-8329 ext. 18 apelso2021.reg@elitepco.com.tw
Posted Date: 02/08/2021
website »

10th EuroELSO Congress 05/04/2022 - 05/06/2022
Location: London, UK
Posted Date: 06/10/2021
website »

ELSO Courses/Workshops

4th Comprehensive Adult ECMO Course 08/27/2021 - 08/28/2021
Location: Fortis Memorial Research Institute, Gurugram, India
Dr. Madhur Arora 9899345337 trainings@enexticu.com
Posted Date: 07/23/2021
website »

Adult ECMO for respiratory failure and septic shock 10/11/2021 - 10/14/2021
Location: Stockholm, Sweden
Björn Frenckner +46707226115 bjorn.frenckner@ki.se
Posted Date: 03/12/2021
website »

Extracorporeal Life Support Adult ECMO Training Course 11/11/2021 - 11/12/2021
Location: Virtual
ecmotraining@elso.org
Posted Date: 01/06/2021

We’ve updated our Privacy Policy. By continuing to use this Service, you acknowledge you’ve read the updated Privacy Policy.